Keywords
Epithelial Ovarian Cancer, Sudan, hospital-based, Omdurman Maternity Hospital
Epithelial Ovarian Cancer, Sudan, hospital-based, Omdurman Maternity Hospital
Ovarian carcinoma (OC) is the second most frequent gynecological cancer in developing countries and globally1,2. They are the fifth most mortal disease in women3,4, and in 2018, ~22,240 new events and 14,070 deaths were associated with OCs in the United States5,6. In Sudan, OCs ranked as the fourth highest malignancy in women, with an incidence rate of ~188 for every 100,000 people, which is 8 for every 100,000 people when gender is specified, and 7 for every 100,000 people with an age-standardized rate7,8.
Epithelial ovarian carcinoma (EOC) is the most widespread and has the highest mortality of OC1,9, with high-grade serous ovarian cancer classed as the deadliest sub-type10,11. In the United State, generally, EOC has been considered an age-related disease; women aged >65 years are considered the target population12,13. Although the incidence of OCs is decreasing, in the majority of cases, distant metastasis is seen at diagnosis14,15. Surgery and chemotherapy are the most important treatments of this cancer but are efficient only in the early stages16,17. Currently; the prognosis for this cancer is still poor, and the five-year survival rate remains low18,19. In Sudan, scarce publications are available about the frequency and incidence of EOC. The present study intended to evaluate the morphological sub-types in Sudan using data from one hospital, sort the disease by age and grade and compare the results with similar studies in other regions of Sudan and other countries.
This was a cross-sectional, hospital-based study performed to determine the frequency of newly diagnosed EOC subtypes, as well as to identify the relationship between subtypes and tumor grades and ages of patients.
The Ethics Committee of Alzaiem Alazhari University and Omdurman Maternity Hospital approved the study and waived informed consent from patients since there was anonymization of patients’ identity and only laboratory numbers were used.
A total of 70 EOC patients from Omdurman Maternity Hospital diagnosed in the period between 2013 and 2018 were selected for this study via convenience sampling. The data were collected in the period between 2016 and 2018. All patients were adult women with OC and no other malignancies. Patients with tiny biopsies, missed blocks, or missing data (more than 50%) were excluded.
Data were collected from hospital records, which included patients’ ages, EOC types, and tumor grades.
The statistical analysis of the collected data was performed using SPSS, version 24 (IBM SPSS). Descriptive analysis was performed for all study variables: EOC types, patient’s ages, and tumor grades. Fisher’s exact test was used for finding statistical significance between EOC types, patients’ ages, and tumor grades. A p-value of <0.05 was considered to be statistically significant.
This study was conducted among 70 new EOC cases. The median age of participants was 50 years (range, 18 – 75 years). In total, 48.6% (n=34) of the participants were in the age group ≤ 50 years(18 to 50 years), and 44.3% (n=31) were in the age group > 50 years (51 to 75 years).The frequency of common histological subtypes is shown in Figure 1. The results showed that the majority of the cases were low grade (51.4%; n=36) compared with high grade (48.6%; n=34).
Our results showed significant associations between EOC tumor types and EOC tumor grades (Fisher’s Exact test, p = 0.000) and no significant associations between tumor types and ages (Fisher’s Exact test, p>0.05).
OCs are the most lethal gynecological malignancy worldwide and constitutes the fifth leading cause of cancer-related death in women20,21. Comparison of the age distribution of new OC cases revealed that the median age of 50 years recorded in this study is similar to a local study from Gezira State, Sudan7, sub-Saharan African22,23 and other developing countries24. Nevertheless, it is lower than that reported from developed countries25, for example a median age of 65 years was reported from the Netherlands26. The lower age in this study may suggest an earlier onset or a more aggressive course of the disease in our environment. Also, it may be because Africa has the youngest population of any of the continents27. Our study results indicate a younger presentation of EOC and warrants quick and thorough investigation of any vague abdominal complaint in women of a younger age (<50 years). In the present study, serous adenocarcinoma is the most frequent histological type (43.1%), which is supported by previous studies28–30.
This research was affected by the inherent limitations of the retrospective type of study. Also, it was reliant on the data extracted from medical records, was based at a single institution-based, and had a small sample size. Finally, there were missing variables for some participants; incomplete or missing documents may lead to the introduction of bias into the study and affect the outcome.
The present study revealed that contrary to some previously published data, EOC affected a larger proportion of younger Sudanese women. The most prevalent subtype of EOC is serous carcinoma. A further study of frequency and prevalence of EOCs in other parts of Sudan is needed.
Figshare: frequency data.csv, https://doi.org/10.6084/m9.figshare.925520031
Data are available under the terms of the Creative Commons Zero “No rights reserved” data waiver (CC0 1.0 Public domain dedication).
We thank the Department of Histopathology and Cytology at Omdurman Maternity Hospital for providing their facilities. We are also thankful to our technician Mr. Hassan for his cooperation during data collection.
Views | Downloads | |
---|---|---|
F1000Research | - | - |
PubMed Central
Data from PMC are received and updated monthly.
|
- | - |
Is the work clearly and accurately presented and does it cite the current literature?
Yes
Is the study design appropriate and is the work technically sound?
Yes
Are sufficient details of methods and analysis provided to allow replication by others?
Partly
If applicable, is the statistical analysis and its interpretation appropriate?
Yes
Are all the source data underlying the results available to ensure full reproducibility?
Yes
Are the conclusions drawn adequately supported by the results?
Partly
Competing Interests: No competing interests were disclosed.
Reviewer Expertise: Cancer research and interest in cancer in Sudan.
Is the work clearly and accurately presented and does it cite the current literature?
Yes
Is the study design appropriate and is the work technically sound?
Partly
Are sufficient details of methods and analysis provided to allow replication by others?
Partly
If applicable, is the statistical analysis and its interpretation appropriate?
Yes
Are all the source data underlying the results available to ensure full reproducibility?
Yes
Are the conclusions drawn adequately supported by the results?
Partly
Competing Interests: No competing interests were disclosed.
Alongside their report, reviewers assign a status to the article:
Invited Reviewers | ||
---|---|---|
1 | 2 | |
Version 1 02 Sep 19 |
read | read |
Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list:
Sign up for content alerts and receive a weekly or monthly email with all newly published articles
Already registered? Sign in
The email address should be the one you originally registered with F1000.
You registered with F1000 via Google, so we cannot reset your password.
To sign in, please click here.
If you still need help with your Google account password, please click here.
You registered with F1000 via Facebook, so we cannot reset your password.
To sign in, please click here.
If you still need help with your Facebook account password, please click here.
If your email address is registered with us, we will email you instructions to reset your password.
If you think you should have received this email but it has not arrived, please check your spam filters and/or contact for further assistance.
Comments on this article Comments (0)